Clin Onc News Staff
Palbociclib Approved for Breast Cancer
The therapy was approved in combination with fulvestrant for the treatment of women with hormone ...
FEBRUARY 22, 2016
Oral HPV 16 Greatly Increases Risk for Head and Neck Cancer
Patients with HPV type 16 are 22 times more likely to develop oropharyngeal SSC than those without HPV 16.
JANUARY 22, 2016
New Therapy Approved for CLL
The therapy is now approved for extended treatment of patients who have achieved a complete or partial ...
JANUARY 20, 2016
Load more